Feng Wang

Shenzhen SiBionics Co., Ltd. engages in the research, development, and commercialization of active implantable medical devices and medical artificial intelligence. Its solutions include retinal prosthesis, continuous glucose monitoring, diabetic retinopathy screening, and gastric cancer screening. The company was founded on April 29, 2015 and is headquartered in Shenzhen, China.

Shenzhen SiBionics Co., Ltd. engages in the research, development, and commercialization of active implantable medical devices and medical artificial intelligence. Its solutions include retinal prosthesis, continuous glucose monitoring, diabetic retinopathy screening, and gastric cancer screening. The company was founded on April 29, 2015 and is headquartered in Shenzhen, China.

Shenzhen SiBionics Co., Ltd. engages in the research, development, and commercialization of active implantable medical devices and medical artificial intelligence. Its solutions include retinal prosthesis, continuous glucose monitoring, diabetic retinopathy screening, and gastric cancer screening. The company was founded on April 29, 2015 and is headquartered in Shenzhen, China.

Shenzhen SiBionics Co., Ltd. engages in the research, development, and commercialization of active implantable medical devices and medical artificial intelligence. Its solutions include retinal prosthesis, continuous glucose monitoring, diabetic retinopathy screening, and gastric cancer screening. The company was founded on April 29, 2015 and is headquartered in Shenzhen, China.

Shenzhen SiBionics Co., Ltd. engages in the research, development, and commercialization of active implantable medical devices and medical artificial intelligence. Its solutions include retinal prosthesis, continuous glucose monitoring, diabetic retinopathy screening, and gastric cancer screening. The company was founded on April 29, 2015 and is headquartered in Shenzhen, China.